Utku Ogan AKYILDIZ

Dr. Utku Ogan AKYILDIZ

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Sleep Medicine
Verified
Journal Article
Closed access
UAUtku Ogan AKYILDIZ
Utku Ogan AKYILDIZ
FTF. Irsel Tezer
F. Irsel Tezer
GKGuray Koc
Guray Koc
SISevda Ismailogullari
Sevda Ismailogullari
ADAylin Bican Demir
Aylin Bican Demir
Gülçin Benbir ŞenelGülçin Benbir Şenel
Gülçin Benbir Şenel

2 April 2014 in Journal of Child Neurology
Verified
Journal Article
Closed access
ATAyşe Tosun
Ayşe Tosun
ŞDŞiar Dursun
Şiar Dursun
UAUtku Ogan AKYILDIZ
Utku Ogan AKYILDIZ
SOSeçil Oktay
Seçil Oktay
CTCengiz Tataroğlu
Cengiz Tataroğlu
Guillain-Barré syndrome is an acute inflammatory autoimmune polyradiculoneuritis. Progressive motor weakness and areflexia are essential for its diagnosis. Hyperreflexia has rarely been reported in the early healing period of Guillain-Barré syndrome following Campylobacter jejuni infection in patients with acute motor axonal neuropathy with antiganglioside antibody positivity. In this study, we report a 12-year-old girl presenting with complaints of inability to walk, numbness in hands and feet, and hyperactive deep tendon reflexes since the onset of the clinical picture, diagnosed with acute motor-sensory axonal neuropathy type of Guillain-Barré syndrome.

1 September 2023 in Journal of Turkish Sleep Medicine
Verified
Journal Article
Closed access
UAUtku Ogan AKYILDIZ
Utku Ogan AKYILDIZ
AGAsli Akyol Gurses
Asli Akyol Gurses

Verified
Journal Article
Open access
PDF file
ADAylin Bican Demir
Aylin Bican Demir
Panagiotis BargiotasPanagiotis Bargiotas
Panagiotis Bargiotas
DBDeniz Tuncel Berktaş
Deniz Tuncel Berktaş
SISevda İsmailoğulları
Sevda İsmailoğulları
UAUtku Ogan AKYILDIZ
Utku Ogan AKYILDIZ
Claudio L.A. BassettiClaudio L.A. Bassetti
Claudio L.A. Bassetti
Background: The clinical evaluation of a patient complaining of excessive daytime sleepiness is of crucial importance for the diagnosis of narcolepsy. The Swiss Narcolepsy Scale (SNS) was developed in 2004 as a screening tool for patients with narcolepsy and shown in three different studies to have a high sensitivity and specificity for narcolepsy type 1 (NT1). The aim of this study was to assess the validity and reliability of the Turkish version of SNS (SNS-TR). Patients and Methods: Twenty-one healthy controls, 26 patients with idiopathic hypersomnia, and 27 patients with narcolepsy were recruited from five accredited sleep centers in Turkey. Pearson’s correlation coefficient and degree of freedom were used to determine the validity of each question. Cronbach’s alpha was calculated to assess the internal consistency or reliability of Likert-type questions. The inter-rater reliability was tested using Cohen’s kappa analysis, and the intra-class correlation coefficient (ICC) was used to evaluate the validity and reliability between two evaluations with a one-month interval. Results: Sensitivity and specificity of SNS-TR were 90.5% and 100%, respectively, for diagnosing NT1. Cronbach’s alpha was 0.976, showing a highly reliable level of internal consistency. The inter-rater reliability of the questions and the validity and reliability between two evaluations were moderate or above. Conclusion: This study provides evidence for the validity and reliability of SNS-TR in diagnosing and discriminating NT1 from other disorders of hypersomnolence with a very high sensitivity and specificity.

29 May 2023 in Journal of Turkish Sleep Medicine
Verified
Journal Article
Closed access
UAUtku Ogan AKYILDIZ
Utku Ogan AKYILDIZ
AAAli Akyol
Ali Akyol

6 June 2024 in Brain and Behavior
Verified
Journal Article
Open access
AGAsli Akyol Gurses
Asli Akyol Gurses
UAUtku Ogan AKYILDIZ
Utku Ogan AKYILDIZ
Objective: Rapid eye movement (REM)‐dependent obstructive sleep apnea syndrome (OSAS) is a specific subtype of OSAS having some phenotypic characteristics like a preference for a younger age, female gender, and milder severity. Such favorable features could make it possible to consider an overall benign course for this phenotype. However, accumulating data introduced its association with several cardiometabolic and vascular disorders recently. The primary objective of this study was to address the disease from the inflammation perspective and evaluate the potential inflammatory status in this variant via two accessible blood parameters: platelet distribution width (PDW) and systemic immune‐inflammation index (SII). The secondary aim was to investigate whether this status, together with other disease characteristics, demonstrates consistency under different definitions of REM‐dependent OSAS published previously.Patients and methods: The medical records of 35 patients with mild‐to‐moderate REM‐dependent OSAS, 35 age‐ and sex‐matched patients with REM‐independent OSAS, and 25 non‐OSA controls were retrospectively analyzed. Baseline features, polysomnographic characteristics, PDW, and SII were compared between the groups. Secondly, the analyses were repeated using different definitions of REM‐dependent OSAS. Bivariate analyses were performed, and a multiple stepwise regression model was applied to adjust for body mass index (BMI) and cardiovascular risk (CVR) factors. Results: Mean PDW and SII were increased in patients with REM‐dependent OSAS as compared to non‐OSA controls (p = .022 and .029). The significance remained stable after adjustment for BMI and CVRs and was consistent according to different definitions. The Comparison of patients with REM‐independent OSAS and non‐OSA controls, as well as the two different subtypes of OSAS, did not yield significance.Conclusion: Based on the current findings, patients with REM‐dependent OSAS appear to be susceptible to inflammation and should be carefully monitored for the negative consequences of that issue. To our knowledge, this study is the first to evaluate SII and PDW in REM‐dependent OSAS.